Article
Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET.
European journal of nuclear medicine and molecular imaging - 1 Jul 2024
Kaiser Lena, Quach S, Zounek A J, Wiestler B, Zatcepin A, Holzgreve A, Bollenbacher A, Bartos L M, Ruf V C, Böning G, Thon N, Herms J, Riemenschneider M J, Stöcklein S, Brendel M, Rupprecht R, Tonn J C, Bartenstein P, von Baumgarten L, Ziegler S, Albert N L
Abstract excerpt
PURPOSE: According to the World Health Organization classification for tumors of the central nervous system, mutation status of the isocitrate dehydrogenase (IDH) genes has become a major diagnostic discriminator for gliomas. Therefore, imaging-based prediction of IDH mutation status is of high interest for individual patient management. We compared and evaluated the diagnostic value of radiomics derived from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
